You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,028,965


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,028,965 protect, and when does it expire?

Patent 10,028,965 protects DEXYCU KIT and is included in one NDA.

This patent has twelve patent family members in eight countries.

Summary for Patent: 10,028,965
Title:Use of sustained release dexamethasone in post-cataract surgery inflammation
Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
Inventor(s): Wong; Vernon G. (Menlo Park, CA), White; William S. (Birmingham, AL), Hu; Mae W. (Los Altos Hills, CA), Huang; Glenn T. (Fremont, CA), Karasina; Faina (Mountain View, CA)
Assignee: ICON BIOSCIENCE, INC. (Newark, CA)
Application Number:14/893,381
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patent 10,028,965: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property protection, allowing inventors to exclude others from making, using, or selling their inventions. This article delves into the specifics of U.S. Patent 10,028,965, focusing on its scope, claims, and the broader patent landscape in which it exists.

What is U.S. Patent 10,028,965?

U.S. Patent 10,028,965, titled "Use of sustained release dexamethasone in post-cataract surgery," pertains to a medical treatment regimen involving a short-term sustained release liquid formulation of dexamethasone in citrate. This invention is designed to manage inflammation and other complications following cataract surgery[4].

Patent Scope and Claims

Definition of Patent Scope

The scope of a patent is defined by its claims, which outline the specific protections granted to the inventor. The claims are essential as they determine the boundaries of what is considered infringing and what is not[2][3].

Claims in U.S. Patent 10,028,965

The patent application for U.S. Patent 10,028,965 includes several claims that specify the composition, method of use, and the benefits of the sustained release dexamethasone formulation. Here are some key aspects of the claims:

  • Composition Claims: These claims detail the specific formulation of the sustained release dexamethasone, including the concentration of dexamethasone and the citrate buffer.
  • Method of Use Claims: These claims describe how the formulation is administered post-cataract surgery, including the dosage and duration of treatment.
  • Benefit Claims: These claims highlight the advantages of using this formulation, such as reduced inflammation and improved patient outcomes[4].

Importance of Claim Language

The language used in the claims is critical. It must be precise and clear to avoid ambiguity and potential litigation. Research has shown that narrower claims, measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process[3].

Patent Application Process

Filing the Application

The application for U.S. Patent 10,028,965 would have followed the standard process administered by the U.S. Patent and Trademark Office (USPTO). This involves submitting a non-provisional or provisional application, which includes a specification, drawings if necessary, an oath or declaration, an application data sheet, and fees[2].

Patent Prosecution

After filing, the application undergoes a review by a patent examiner to ensure compliance with legal requirements. This includes a prior art search to determine if the claimed invention is useful, novel, and non-obvious. If the examiner finds issues, an Office Action is issued, and the applicant must address these concerns before the patent can be granted[2].

Patent Landscape: Trends and Categories

Technology Areas

Patents are classified into various technology areas, which help in analyzing trends. For medical inventions like U.S. Patent 10,028,965, the relevant categories might include chemistry and pharmaceuticals. The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields for international comparisons[1].

Recent Trends

In recent years, there has been a significant increase in patents related to information and communication technologies (ICT), as well as in the fields of electrical and mechanical engineering. However, medical and pharmaceutical patents also remain a vital area of innovation, reflecting ongoing research and development in healthcare[1].

Intellectual Property Protection

Types of Patents

U.S. Patent 10,028,965 is a utility patent, which protects the functional aspects of the invention. Other types of patents include design patents, which protect the visual ornamental characteristics, and plant patents, which protect hybridized plants[2].

Trade Secrets and Trademarks

While patents are primary indicators of invention, trade secrets and trademarks are also crucial for intellectual property protection. For R&D-performing firms, trademarks are as important as patents in safeguarding new products and processes[1].

Challenges and Debates

Patent Quality and Scope

There is ongoing debate about the quality and scope of patents. Some argue that broader patents can diminish innovation incentives due to increased licensing and litigation costs. Research suggests that narrower claims during the examination process are associated with a higher grant rate and shorter examination times[3].

Small Claims Patent Court

To address some of these challenges, there have been discussions about establishing a small claims patent court. This would aim to provide a more streamlined and cost-effective process for resolving patent disputes, particularly for small inventors and businesses[5].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be clear and precise.
  • Claims: Essential for determining the protection granted to the inventor.
  • Patent Application Process: Involves filing with the USPTO, review by a patent examiner, and potential Office Actions.
  • Technology Areas: Classified using the WIPO system, with trends showing growth in ICT and engineering fields.
  • Intellectual Property Protection: Includes utility, design, and plant patents, as well as trade secrets and trademarks.
  • Challenges and Debates: Ongoing discussions about patent quality, scope, and the potential for a small claims patent court.

FAQs

What is the primary purpose of the claims in a patent application?

The primary purpose of the claims in a patent application is to define the scope of the patent's protection, outlining what is considered infringing and what is not.

How is the scope of a patent measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which have been shown to have explanatory power for several correlates of patent scope.

What types of patents are available for protecting inventions?

There are three main types of patents: utility patents, design patents, and plant patents. Utility patents protect the functional aspects of an invention, design patents protect the visual ornamental characteristics, and plant patents protect hybridized plants.

Why is the language used in patent claims important?

The language used in patent claims must be precise and clear to avoid ambiguity and potential litigation. Narrower claims are associated with a higher probability of grant and a shorter examination process.

What is the role of the USPTO in the patent application process?

The USPTO administers the patent application process, including the review by a patent examiner to ensure compliance with legal requirements, and the issuance of Office Actions if issues are found.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,028,965

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF POSTOPERATIVE INFLAMMATION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,028,965

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014268434 ⤷  Subscribe
Canada 2913336 ⤷  Subscribe
China 105407896 ⤷  Subscribe
China 110339153 ⤷  Subscribe
European Patent Office 3003318 ⤷  Subscribe
European Patent Office 4082525 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.